Stockholders’ Equity

12 Months Ended

Mar. 31, 2026

Stockholders' Equity Note [Abstract]

Stockholders’ Equity

Stockholders’ Equity

Stock Repurchase Program. The Board has approved a stock repurchase program which authorizes the

Company to repurchase shares of its common stock in the open market or in privately negotiated transactions,

subject to market conditions, applicable legal requirements, and other factors (collectively, the stock repurchase

program). The Board last approved an authorization of $2,250,000 on May 21, 2025, to repurchase shares of the

Company’s common stock under the same conditions as the prior stock repurchase program. As of March 31, 2026,

the aggregate remaining approved amount under the stock repurchase program is $1,549,602.

The stock repurchase program does not obligate the Company to acquire any amount of common stock and may be

suspended at any time at the Company’s discretion. The credit agreements governing the Company’s revolving

credit facilities allow it to make stock repurchases under this program, so long as it does not exceed certain

leverage ratios. As of March 31, 2026, the Company has not exceeded the stated leverage ratios, and no defaults

have occurred under these credit agreements.

Stock repurchase activity under the Company’s stock repurchase program was as follows:

	Years Ended March 31,
	2026	2025	2024
Total number of shares repurchased (1)	10,496,292	3,800,040	4,289,124
Weighted average price per share	$102.43	$149.21	$96.74
Dollar value of shares repurchased (2) (3)	$1,075,100	$567,002	$414,931

(1) All share repurchases were made pursuant to the stock repurchase program in open-market transactions.

(2) May not calculate on rounded amounts.

(3) The dollar value of shares repurchased excludes the cost of broker commissions, excise taxes, and other costs.

Subsequent to March 31, 2026, through May 1, 2026, the Company repurchased 1,096,908 shares of its common

stock at a weighted average price of $105.75 per share for $115,999. As of May 1, 2026, the Company had

$1,433,603 for repurchases remaining authorized under the stock repurchase program.

On May 20, 2026, the Board approved an additional authorization of $3,500,000, for the Company to repurchase its

common stock under the same conditions as the prior stock repurchase program, resulting in an aggregate

remaining authorization of approximately $4,840,000 as of that date.

Accumulated Other Comprehensive Loss. The components within AOCL, net of tax, recorded in the consolidated

balance sheets, are as follows:

	As of March 31,
	2026	2025
Unrealized gain on cash flow hedges	$5,564	$1,584
Cumulative foreign currency translation loss	(41,483)	(51,238)
Total	$(35,919)	$(49,654)